Issuer readies rare life sciences securitization
A business development company that specializes in making loans to venture capital backed life sciences and technology companies is in the market this week with a $200m securitization.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ European securitization issuance database
- ✔ Daily newsletters across markets and asset classes
- ✔ 1 weekly securitization podcast